- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Indian radiology association secretary suspended for fetal sex determination test
A regional secretary of the Indian Radiology and Imaging Association and two other doctors were accused of conducting sex determination tests on decoy patients, according to an article in the Times of India.
A regional secretary of the Indian Radiology and Imaging Association and two other doctors were accused of conducting sex determination tests on decoy patients, according to an article in the Times of India. This incident indicates a fresh clampdown on Indian radiologists by the authorities. Conveying the sex of a fetus is illegal in India under the Pre-Conception and Pre-Natal Diagnostic Techniques Act of 1994 .
Dr. Basant Kishore Vyas, the Secretary of the Rajasthan State Chapter of the Indian Radiology and Imaging Association (IRIA), Dr. Maya Sharma, and Dr. Madhurani Jain will be suspended for their actions as well as have their practice licenses revoked, according to the article. In addition, the ultrasound machines and all related documents were seized by state Pre-Conception and Pre-Natal Diagnostic Techniques Act (PC-PNDT) investigators.
The Secretary General of IRIA, Dr. Rajesh Kapur said if the allegations against Vyas are true, the association will initiate strict action against him.
PC-PNDT aims to prevent the misuse of ultrasound for the purpose of sex-selective abortions, which mainly target female fetuses. The act has been a point of contention for Indian radiologists who argue it penalizes many law-abiding citizens. Many get snared for minor infractions such as forgetting a signature on a form, according to Prof. Kishor Taori, president of IRIA. Despite the stringent guidelines, Taori said recently IRIA will “strive hard for strict implementation of PC-PNDT Act without causing any harassment to our honest doctors.”
He and other radiologists cite anecdotal evidence of heavy-handed, even corrupt, officials cashing in on busy ultrasound clinics with large clinical workloads.
As Diagnostic Imaging previously reported, a New Delhi-based PNDT Act committee of radiologists is working on improvements to the wording of the act, and a proposal for guidelines to be applied by those enforcing it. Specialists involved in obstetric imaging should be free to carry out their work unhampered, with lighter penalties, such as warnings, and a chance to rectify mistakes for less serious paperwork errors, according to one source.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.
FDA Clears AI-Powered Cardiovascular Ultrasound System from Siemens Healthineers
August 13th 2024Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.
